<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高解释</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1Vuepj4z_tesaaxkwjxbogotaabxd6u-nvu8003krcpqpqpqpqpq8ylq-ym_sourm_sourm_source = Chrome cce = Chrome umece = Chrome ume 414＆fc = 20230708114047＆utm_medium = rss＆utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQPQ8YLQC-＆FF = 2025040616126＆FF = 2025040616126＆ITM_CAIGH = PUPUP<description>心血管高额外版：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250406161126&amp;utm_campaign=pubmed-2" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>太阳，2025年4月6日20:11:27 +0000</lastbuilddate><pubDate> Sat, 05 Apr 2025 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>通道突触介导气道受保护的化学反射的神经传递</title><link/>https://pubmed.ncbi.nlm.nih.gov/40187347/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>喉咙中化学物质的神经反射可保护气道免受抽吸和感染。对这些反射的机械理解仍然过早，以慢性咳嗽 - 敏感的咳嗽 - 敏感的咳嗽 - 普遍未满足的临床需求。在这里，在小鼠中，对通道突触的全身搜索CALHM1/3通道介导的神经递质的释放和单细胞转录组学发现了POU2F3^（+）化学体感细胞家族的子类，并与... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年4月2日：S0092-8674（25）00280-6。 doi：10.1016/j.cell.2025.03.007。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">喉咙中化学物质的神经反射可保护气道免受抽吸和感染。对这些反射的机械理解仍然过早，以慢性咳嗽 - 敏感的咳嗽 - 敏感的咳嗽 - 普遍未满足的临床需求。 Here, in mice, a whole-body search for channel synapses-featuring CALHM1/3 channel-mediated neurotransmitter release-and single-cell transcriptomics uncovered subclasses of the Pou2f3 <sup>+</sup> chemosensory cell They express G protein-coupled receptors (GPCRs) for noxious chemicals, T2Rs, which upon stimulation trigger swallow and coug-like expulsive reflexes in the下咽和喉。这些反射被CALHM3和POU2F3敲除，可以通过靶向的光遗传刺激触发。此外，空气过敏原暴露增强了CALHM3依赖性驱除反射。这项研究将通道突触的POU2F3 <sup>+</sup>上皮细胞鉴定为气道受保护反射的化学感应最终器官，并具有其过度反应性的部位，从而促进了对气道防御计划的机械理解，具有明显的治疗潜力。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40187347/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40187347</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.03.007>10.1016/j.cell.2025.03.007</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40187347</guid><pubDate> Sat, 05 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Shogo Soma</dc:creator><dc:creator> Norihito Hayatsu</dc:creator><dc:creator> Kengo Nomura</dc:creator><dc:creator>马克·W·舍伍德</dc:creator><dc:creator>穆拉卡米tatro</dc:creator><dc:creator> yoichiro sugiyama</dc:creator><dc:creator> Naofumi Suematsu</dc:creator><dc:creator> Takanori Aoki</dc:creator><dc:creator> Yu Yamada</dc:creator><dc:creator> Moe Asayama</dc:creator><dc:creator> Mami Kaneko</dc:creator><dc:creator> Kento Ohbayashi</dc:creator><dc:creator> Misa Arizono</dc:creator><dc:creator> Masato Ohtsuka</dc:creator><dc:creator> Shun Hamada</dc:creator><dc:creator> Ichiro Matsumoto</dc:creator><dc:creator> Yusaku Iwasaki</dc:creator><dc:creator> nobuhiko ohno</dc:creator><dc:creator> Yasushi Okazaki</dc:creator><dc:creator> Akiyuki Taruno</dc:creator><dc:date> 2025-04-05</dc:date><dc:source>细胞</dc:source><dc:title>通道突触介导气道受保护的化学反射的神经传递</dc:title><dc:identifier>PMID：40187347</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.03.007</dc:identifier></item><item><title>肠道微生物定植的保守遗传基础</title><link/>https://pubmed.ncbi.nlm.nih.gov/40187346/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign = pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>尽管肠道微生物具有根本的重要性，但其定殖的遗传基础在很大程度上仍然是意外的。在这里，通过在寿命量表上应用跨物种基因型 - 比塔特缔合，我们确定了与肠道定植相关的保守微生物基因模块。在成千上万的物种中，我们发现了79种分类学多样化的推定定植因子，这些因素组织到了歌剧和非术模块中。它们包括先前表征的定植途径，例如... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年4月2日：S0092-8674（25）00283-1。 doi：10.1016/j.cell.2025.03.010。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">尽管肠道微生物具有根本的重要性，但其定殖的遗传基础在很大程度上仍然是意外的。在这里，通过在寿命量表上应用跨物种基因型 - 比塔特缔合，我们确定了与肠道定植相关的保守微生物基因模块。在成千上万的物种中，我们发现了79种分类学多样化的推定定植因子，这些因素组织到了歌剧和非术模块中。它们包括先前表征的定植途径，例如自诱导剂-2生物合成和新过程，包括tRNA修饰和翻译。体内功能验证揭示了大肠杆菌肠道定植所必需的yigz（撞击家族）和tRNA羟基化蛋白-P（TRHP）。单独表达的yigz足以增强较差的MG1655大肠杆菌的定殖>; 100倍。此外，YIGZ的自然等位基因变化会影响交通间定殖效率。我们的发现突出了大规模比较基因组学在揭示微生物适应的遗传基础方面的力量。这些广泛保守的定殖因子可能证明对于理解胃肠道（GI）营养不良和发展治疗至关重要。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40187346/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40187346</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.03.010>10.1016/j.cell.2025.03.010</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40187346</guid><pubDate> Sat, 05 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Menghan Liu</dc:creator><dc:creator>悉尼B布拉特曼</dc:creator><dc:creator>迈高桥</dc:creator><dc:creator>Nandan Mandayam</dc:creator><dc:creator> Wenyan Jiang</dc:creator><dc:creator> Panos Oikonomou</dc:creator><dc:creator> Sohail F Tavazoie</dc:creator><dc:creator> Saeed Tavazoie</dc:creator><dc:date> 2025-04-05</dc:date><dc:source>细胞</dc:source><dc:title>肠道微生物定植的保守遗传基础</dc:title><dc:identifier>PMID：40187346</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.03.010</dc:identifier></item><item><title>通过脑刺病毒的转移受体识别的分子基础</title><link/>https://pubmed.ncbi.nlm.nih.gov/40187345/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>西部马脑炎病毒（WEEV）是一种蛋白质病毒，历史上在整个美洲引起了大规模的脑炎。 WEEV将方案丝蛋白10（PCDH10）作为受体结合，高毒的祖先WEEV菌株还结合了低密度脂蛋白受体（LDLR）相关蛋白。由于韦夫（Weev）在过去的一个世纪中被人类病原体下降，因此分离株失去了结合哺乳动物受体的能力，同时仍然识别禽受体。解释... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年4月2日：S0092-8674（25）00347-2。 doi：10.1016/j.cell.2025.03.029。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">西部马脑炎病毒（WEEV）是一种蛋白质病毒，历史上在整个美洲引起了大规模的脑炎。 WEEV将方案丝蛋白10（PCDH10）作为受体结合，高毒的祖先WEEV菌株还结合了低密度脂蛋白受体（LDLR）相关蛋白。由于韦夫（Weev）在过去的一个世纪中被人类病原体下降，因此分离株失去了结合哺乳动物受体的能力，同时仍然识别禽受体。为了解释受体依赖性的转移并评估WEEV重新出现的风险，我们确定了与人PCDH10，AVIAN PCDH10和人类非常低密度脂蛋白受体（VLDLR）结合的WEEV的冷冻显微镜显微镜结构（VLDLR）。我们表明，一到三个E2糖蛋白取代足以使非致病性菌株保持结合哺乳动物受体的能力。可溶性VLDLR片段可通过致命的祖先WEEV菌株保护小鼠免受致命挑战。由于Weev最近在南美重新出现了数十年的不活动，因此我们的发现对爆发的准备具有重要意义。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40187345/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40187345</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.03.029>10.1016/j.cell.2025.03.029</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40187345</guid><pubDate> Sat, 05 Apr 2025 06:00:00 -0400</pubDate><dc:creator>小火粉丝</dc:creator><dc:creator>Wanyu li</dc:creator><dc:creator>杰西卡·奥罗斯（Jessica Oros）</dc:creator><dc:creator>杰西卡（Jessica）</dc:creator><dc:creator>布鲁克·米切尔（Brooke M Mitchell）</dc:creator><dc:creator>杰西的plung</dc:creator><dc:creator> Himanish Basu</dc:creator><dc:creator> Sivapratha Nagappan-Chettiar</dc:creator><dc:creator>约书亚·M·波克斯（Joshua M Boeckers）</dc:creator><dc:creator> Laurentia v Tjang</dc:creator><dc:creator>科林·J·曼恩（Colin J Mann）</dc:creator><dc:creator> Vesna Brusic</dc:creator><dc:creator> Tierra K Buck</dc:creator><dc:creator>海莉·瓦纳姆（Haley Varnum）</dc:creator><dc:creator>潘阳</dc:creator><dc:creator>Linzy M Malcolm</dc:creator><dc:creator>所以你是崔</dc:creator><dc:creator>威廉·苏扎（William M de Souza）</dc:creator><dc:creator>艾萨克（Isaac M Chiu）</dc:creator><dc:creator> Hisashi umemori</dc:creator><dc:creator> Scott C Weaver</dc:creator><dc:creator>肯尼思·普兰特（Kenneth S Plante）</dc:creator><dc:creator>乔纳森·亚伯拉罕（Jonathan Abraham）</dc:creator><dc:date> 2025-04-05</dc:date><dc:source>细胞</dc:source><dc:title>通过脑刺病毒的转移受体识别的分子基础</dc:title><dc:identifier>PMID：40187345</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.03.029</dc:identifier></item><item><title>通过脑α病毒在受体互动中可塑性的结构基础</title><link/>https://pubmed.ncbi.nlm.nih.gov/40187344/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>尽管对病毒的适应和出现有影响，但受体使用率转移的结构基础仍然很少理解。西部马脑炎病毒（WEEV）菌株暴露了其两个入口受体的不同参与模式：非常低密度的脂蛋白受体（VLDLR）和QooldentHerin 10（PCDH10）。使用结构和功能研究，我们表明，虽然所有WEEV菌株都在E1融合环附近具有脂蛋白A类（LA）结构域结合位点，但VLDLR ... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年4月2日：S0092-8674（25）00272-7。 doi：10.1016/j.cell.2025.02.036。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">尽管对病毒的适应和出现有影响，但受体使用率转移的结构基础仍然很少理解。西部马脑炎病毒（WEEV）菌株暴露了其两个入口受体的不同参与模式：非常低密度的脂蛋白受体（VLDLR）和QooldentHerin 10（PCDH10）。使用结构和功能研究，我们表明，尽管所有WEEV菌株在E1融合回路附近都有脂蛋白A类（LA）结构域结合位点，但VLDLR的参与需要E2中的第二个结合位点，该位点可以随单核苷的替代而变化。我们还解决了与WEEV结合的PCDH10的结构，该结构揭示了E1融合回路附近的相互作用与残差也介导LA结构域结合。进化分析能够生成PCDH10诱饵，该诱饵可保护体内免受所有测试的WEEV菌株。我们的实验证明了病毒如何使用共享的确定剂可以吸引多个接收器，这可能会影响细胞的向量和病毒。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40187344/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40187344</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.02.036>10.1016/j.cell.2025.02.036</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40187344</guid><pubDate> Sat, 05 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Saravanan Raju</dc:creator><dc:creator> Sathvik Palakurty</dc:creator><dc:creator>艾伦·萨里奥尔（Alan Sariol）</dc:creator><dc:creator> Ngan Wagoner</dc:creator><dc:creator>卢卡斯·亚当斯（Lucas J Adams）</dc:creator><dc:creator> Sean Hui</dc:creator><dc:creator> William B Klimstra</dc:creator><dc:creator>戴维德·H弗里蒙特</dc:creator><dc:creator>迈克尔的钻石</dc:creator><dc:date>2025-04-05</dc:date><dc:source>细胞</dc:source><dc:title>通过脑α病毒在受体互动中可塑性的结构基础</dc:title><dc:identifier>PMID：40187344</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.036</dc:identifier></item><item><title>保留心脏移植的未来</title><link/>https://pubmed.ncbi.nlm.nih.gov/40185874/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol。 2025年4月4日。DOI：10.1038/S41569-025-01146-X。在线印刷。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40185874/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40185874</a> | doi： <a href=https://doi.org/10.1038/s41569-025-01146-x>10.1038/s41569-025-01146-X</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40185874</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator>大卫·M·凯（David M Kaye）</dc:creator><dc:creator>大卫C麦吉芬</dc:creator><dc:date>2025-04-04</dc:date><dc:source>自然评论。心脏病学</dc:source><dc:title>保留心脏移植的未来</dc:title><dc:identifier>PMID：40185874</dc:identifier><dc:identifier> doi：10.1038/s41569-025-01146-X</dc:identifier></item><item><title>单细胞空间转录组图集和猕猴的全脑连接性</title><link/>https://pubmed.ncbi.nlm.nih.gov/40185102/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description> Claustrum通过与许多大脑区域的联系来协调大脑功能，但其分子和细胞组织仍未解决。 227,750个猕猴的单核RNA测序鉴定了48种转录组定义的细胞类型，大多数谷氨酸能神经元类似于深层的岛状神经元。猕猴，果果和小鼠转录组的比较揭示了猕猴特异性细胞类型。 67皮层和7个皮层的逆行示踪剂注射... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年3月30日：S0092-8674（25）00273-9。 doi：10.1016/j.cell.2025.02.037。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Claustrum通过与许多大脑区域的联系来协调大脑功能，但其分子和细胞组织仍未解决。 227,750个猕猴的单核RNA测序鉴定了48种转录组定义的细胞类型，大多数谷氨酸能神经元类似于深层的岛状神经元。猕猴，果果和小鼠转录组的比较揭示了猕猴特异性细胞类型。 67皮层和7个皮层区域的逆行示踪剂注射定义了逆行标记的clafustral神经元的四个不同的分布区。全脑连通性和单细胞空间转录组的联合分析表明，这四个区域包含不同的谷氨酸能（但不是GABA能）细胞类型的组成，优先连接了具有较强的同侧偏置的特定大脑区域。腹侧与背部环境区域中的几种猕猴特异性谷氨酸能细胞类型分别对两个功能相关的区域 - 内嗅皮层和海马与运动皮层和运动皮层和ptamen进行了选择。这些数据为阐明了潜水员claustral功能的神经元组织提供了基础。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40185102/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40185102</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.02.037>10.1016/j.cell.2025.02.037</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40185102</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator> ying lei</dc:creator><dc:creator> Yuxuan Liu</dc:creator><dc:creator> Mingli Wang</dc:creator><dc:creator>尼尼元</dc:creator><dc:creator>Yujie Hou</dc:creator><dc:creator> lingjun ding</dc:creator><dc:creator> Zhiyong Zhu</dc:creator><dc:creator> Zihan Wu</dc:creator><dc:creator> Chao Li</dc:creator><dc:creator> Mingyuan Zheng</dc:creator><dc:creator> Ruiyi Zhang</dc:creator><dc:creator> ana rita ribeiro gomes</dc:creator><dc:creator> Yuanfang Xu</dc:creator><dc:creator> Zhaoke Luo</dc:creator><dc:creator>刘</dc:creator><dc:creator>Qinwen Chai</dc:creator><dc:creator>皮埃尔·痛苦</dc:creator><dc:creator>Yanqing Zhong</dc:creator><dc:creator> Xinxiang歌曲</dc:creator><dc:creator>卡米尔·拉米（Camille Lamy）</dc:creator><dc:creator> wei cui</dc:creator><dc:creator> Qian Yu</dc:creator><dc:creator> Jiao fang</dc:creator><dc:creator> yingjie an</dc:creator><dc:creator>你们天</dc:creator><dc:creator>Yiwen Liu</dc:creator><dc:creator> Xing Sun</dc:creator><dc:creator> Ruiqi Wang</dc:creator><dc:creator> Huanhuan li</dc:creator><dc:creator> Jingjing歌</dc:creator><dc:creator>棕褐色</dc:creator><dc:creator>他王</dc:creator><dc:creator>Shiwen Wang</dc:creator><dc:creator>灵汉</dc:creator><dc:creator>张张</dc:creator><dc:creator>Shenyu li</dc:creator><dc:creator> Kexin Wang</dc:creator><dc:creator>王王</dc:creator><dc:creator>Wanqiu周</dc:creator><dc:creator>刘刘</dc:creator><dc:creator>康</dc:creator><dc:creator>Shuzhen Zhang</dc:creator><dc:creator> liangtang chang</dc:creator><dc:creator> Dafina Toplaj</dc:creator><dc:creator> Mengni Chen</dc:creator><dc:creator> Jiabing Liu</dc:creator><dc:creator> Yun Zhao</dc:creator><dc:creator> Biyu Ren</dc:creator><dc:creator> hanyu shi</dc:creator><dc:creator>张张</dc:creator><dc:creator>Haotian Yan</dc:creator><dc:creator>贾亚扬马</dc:creator><dc:creator>莉娜·王（Lina Wang）</dc:creator><dc:creator> li</dc:creator><dc:creator> Yichen Zuo</dc:creator><dc:creator> linjie lu</dc:creator><dc:creator> Liqin Gu</dc:creator><dc:creator>关闭李</dc:creator><dc:creator>Yaqian Wang</dc:creator><dc:creator> y</dc:creator><dc:creator> Shengkang li</dc:creator><dc:creator>张张</dc:creator><dc:creator>YANBING LU</dc:creator><dc:creator> Yannong Dou</dc:creator><dc:creator> liu</dc:creator><dc:creator> Anqi Zhao</dc:creator><dc:creator> Minyuan Zhang</dc:creator><dc:creator> Xinyan Zhang</dc:creator><dc:creator> xia</dc:creator><dc:creator> Wei Zhang</dc:creator><dc:creator> Huateng Cao</dc:creator><dc:creator> Zhiyue lu</dc:creator><dc:creator> Zixian Yu</dc:creator><dc:creator> Xin li</dc:creator><dc:creator>小王王</dc:creator><dc:creator>希芬·梁</dc:creator><dc:creator>Shengjin Xu</dc:creator><dc:creator> Ciron Liu</dc:creator><dc:creator>郑郑</dc:creator><dc:creator>Chun Xu</dc:creator><dc:creator> Zhiyong Liu</dc:creator><dc:creator>李元</dc:creator><dc:creator>YAN-GANG太阳</dc:creator><dc:creator>Xun Xu</dc:creator><dc:creator> Colette Dehay</dc:creator><dc:creator>朱利安·维佐利（Julien Vezoli）</dc:creator><dc:creator> Mu-ming便便</dc:creator><dc:creator>Jianhua Yao</dc:creator><dc:creator> Longqi Liu</dc:creator><dc:creator> Wu Wei</dc:creator><dc:creator>亨利·肯尼迪</dc:creator><dc:creator>zhiming shen</dc:creator><dc:date> 2025-04-04</dc:date><dc:source>细胞</dc:source><dc:title>单细胞空间转录组图集和猕猴的全脑连接性</dc:title><dc:identifier>PMID：40185102</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.037</dc:identifier></item><item><title> RORγT阳性树突状细胞是对口服抗原诱导外周调节T细胞所必需的</title><link/>https://pubmed.ncbi.nlm.nih.gov/40185101/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign = pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>肠道免疫抑制剂通过周围衍生的RORγT^（+）Tregs（Ptregs）（PTREGS）对无害的食物蛋白和肠道菌群的耐受性，从而预防食物摄入剂和炎症性肠病。最近的研究表明，RORγT^（+）抗原呈递细胞（APC），其中包括稀有的树突状细胞（DC）亚群和3型先天淋巴样细胞（ILC3S），是PTREG诱导的关键。在这里，我们通过删除特定的顺式调节性...开发了一种具有降低RORγT^（+）APC的小鼠... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年4月1日：S0092-8674（25）00293-4。 doi：10.1016/j.cell.2025.03.020。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">肠道免疫抑制剂通过周围衍生的RORγT <sup>+</sup> Tregs（Ptregs）（PTREGS）对无害食物蛋白和肠道菌群的耐受性，从而阻止食物摄入剂和炎症性肠病。最近的研究表明，包括稀有树突状细胞（DC）亚群和3型先天淋巴样细胞（ILC3S）的RORγT <sup>+</sup>抗原细胞（APC）是PTREG诱导的关键。在这里，我们通过删除编码RORγT的RORC的特定顺式调节元件来开发具有降低RORγT <sup>+</sup> APC的小鼠。单细胞RNA测序和流式细胞仪分析证实了RORγT <sup>+</sup> DC子集和ILC3的耗竭。这些小鼠表现出ptregs的继发性降低，对口服抗原的耐受性受损，而T助手（Th）2细胞的增加。相反，ILC3缺陷小鼠没有ptregs或Th2细胞异常。谱系跟踪表明，RORγT <sup>+</sup> DCs与ILC3共享淋巴样，与它们相似的表型性状一致。这些发现突出了淋巴样RORγT <sup>+</sup> DC在维持肠道免疫平衡和预防食物过敏等疾病中的作用。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40185101/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40185101</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.03.020>10.1016/j.cell.2025.03.020</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40185101</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator>帕特里克·费尔南德斯·罗德里格斯（Patrick Fernandes Rodrigues）</dc:creator><dc:creator>乌斯·吴</dc:creator><dc:creator>Tihana trsan</dc:creator><dc:creator> Santosh K Panda</dc:creator><dc:creator> JoséLuísFachi</dc:creator><dc:creator> Yizhou Liu</dc:creator><dc:creator>锡林</dc:creator><dc:creator>莎拉·德·奥利维拉（Sarah de Oliveira）</dc:creator><dc:creator> Alina Ulezko Antonova</dc:creator><dc:creator> Darya Khantakova</dc:creator><dc:creator>拉基·苏丹</dc:creator><dc:creator>Pritesh Desai</dc:creator><dc:creator>迈克尔的钻石</dc:creator><dc:creator>苏珊·吉尔菲兰（Susan Gilfillan）</dc:creator><dc:creator>斯蒂芬·K·安德森（Stephen K Anderson）</dc:creator><dc:creator>码头牢房</dc:creator><dc:creator>Marco Colonna</dc:creator><dc:date> 2025-04-04</dc:date><dc:source>细胞</dc:source><dc:title>RORγT阳性树突状细胞是对口服抗原诱导外周调节T细胞所必需的</dc:title><dc:identifier>PMID：40185101</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.03.020</dc:identifier></item><item><title> PAX易位重塑线粒体代谢，通过横纹肌肉瘤中的亮氨酸使用改变</title><link/>https://pubmed.ncbi.nlm.nih.gov/40185100/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>带有成对盒融合蛋白（PAX3/7-FOXO1）的肺泡横纹肌肉瘤（ARM）患者表现出更大的肿瘤缓解，转移和生存不良的事件，因此迫切需要开发有效疗法来治疗这种儿童癌症的有效疗法。为了揭示有助于肿瘤创新的机制，我们开发了肌肉祖细胞模型，并使用表观基因组方法来阐明由PAX3/7融合蛋白介导的基因组重新布线。在钥匙... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年4月1日：S0092-8674（25）00281-8。 doi：10.1016/j.cell.2025.03.008。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">带有成对盒融合蛋白（PAX3/7-FOXO1）的肺泡横纹肌肉瘤（ARM）患者表现出更大的肿瘤缓解，转移和生存不良的事件，因此迫切需要开发有效疗法来治疗这种儿童癌症的有效疗法。为了揭示有助于肿瘤创新的机制，我们开发了肌肉祖细胞模型，并使用表观基因组方法来阐明由PAX3/7融合蛋白介导的基因组重新布线。在PAX3/7融合蛋白的关键靶标中，我们确定了癌基因的队列，成纤维细胞生长因子（FGF）受体，tRNA修饰酶以及对线粒体代谢和蛋白质转化必不可少的基因，我们成功地靶向了Preclinical试验。我们将亮氨酸的用法视为推动侵袭性PAX融合肿瘤生长的关键因素，因为它限制了其生物利用度受损的氧化物磷酸化和线粒体代谢，从而延迟了肿瘤的进展并改善了体内生存率。我们的数据提供了令人信服的可行目标清单，并提出了有希望治疗该肿瘤的新策略。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40185100/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40185100</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.03.008>10.1016/j.cell.2025.03.008</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40185100</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Bhargab Kalita</dc:creator><dc:creator> Gerard Martinez-Cebrian</dc:creator><dc:creator>贾斯蒂娜·麦克维（Justina McEvoy）</dc:creator><dc:creator>旋律Allensworth</dc:creator><dc:creator>米歇尔·奈特</dc:creator><dc:creator>亚历山德罗·马格里（Alessandro Magli）</dc:creator><dc:creator> Rita Cr Perlingeiro</dc:creator><dc:creator>迈克尔染色器</dc:creator><dc:creator>伊丽莎白·斯图尔特</dc:creator><dc:creator>Brian David Dynlacht</dc:creator><dc:date> 2025-04-04</dc:date><dc:source>细胞</dc:source><dc:title>PAX易位重塑线粒体代谢，通过横纹肌肉瘤中的亮氨酸使用改变</dc:title><dc:identifier>PMID：40185100</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.03.008</dc:identifier></item><item><title> 20年组蛋白赖氨酸脱甲基酶：从发现到诊所及以后</title><link/>https://pubmed.ncbi.nlm.nih.gov/40185081/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>二十年前，发现了组蛋白赖氨酸脱甲基酶（KDMS）。自从发现以来，它们越来越多地研究，并且在物种，发育和疾病中都很重要。在理解其（1）酶学，（2）作为生物复合物的关键成分的作用，（3）在正常细胞过程和功能中的作用，（4）在病理条件中的影响以及（5）治疗潜力中的作用，已取得了重大进展。评论涵盖了这些关键... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>。 2025年4月3日； 188（7）：1747-1783。 doi：10.1016/j.cell.2025.02.023。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">二十年前，发现了组蛋白赖氨酸脱甲基酶（KDMS）。自从发现以来，它们越来越多地研究，并且在物种，发育和疾病中都很重要。在理解其（1）酶学，（2）作为生物复合物的关键成分的作用，（3）在正常细胞过程和功能中的作用，（4）在病理条件中的影响以及（5）治疗潜力中的作用，已取得了重大进展。评论涵盖了与KDM领域相关的这些关键关系，意识到许多实验室为这一领域做出了贡献。当前的知识结合未来的见解将影响我们对细胞功能，发育以及疾病发作和进展的理解，这将允许鉴定出新型的生物标志物，并在未来几年为KDM相关疾病开发最佳的治疗选择。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40185081/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40185081</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.02.023>10.1016/j.cell.2025.02.023</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40185081</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Zach H Gray</dc:creator><dc:creator>麦迪逊荣誉</dc:creator><dc:creator>Pooja Ghatalia</dc:creator><dc:creator>杨什</dc:creator><dc:creator>Johnathan R Whetstine</dc:creator><dc:date> 2025-04-04</dc:date><dc:source>细胞</dc:source><dc:title>20年组蛋白赖氨酸脱甲基酶：从发现到诊所及以后</dc:title><dc:identifier>PMID：40185081</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.02.023</dc:identifier></item><item><title> Tirzepatide，HFPEF和肾脏：需要测量GFR的三角关系，不猜测</title><link/>https://pubmed.ncbi.nlm.nih.gov/40183720/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol。 2025年3月31日：S0735-1097（25）05983-2。 doi：10.1016/j.jacc.2025.03.508。在线印刷。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40183720/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40183720</a> | doi： <a href=https://doi.org/10.1016/j.jacc.2025.03.508>10.1016/j.jacc.2025.03.508</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40183720</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Jozine M Ter Maaten</dc:creator><dc:creator> Javed Butler</dc:creator><dc:date> 2025-04-04</dc:date><dc:source>美国心脏病学院杂志</dc:source><dc:title>Tirzepatide，HFPEF和肾脏：需要测量GFR的三角关系，不猜测</dc:title><dc:identifier>PMID：40183720</dc:identifier><dc:identifier> doi：10.1016/j.jacc.2025.03.508</dc:identifier></item><item><title>冠状动脉疾病的遗传和生活方式风险以及出现痴呆症亚型的长期风险</title><link/>https://pubmed.ncbi.nlm.nih.gov/40181791/?utm_source=chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>结论：在遗传上易于发展CAD的个体也面临着在老年内发展痴呆症的风险。在寿命早期证明健康生活方式概况的人中，这种风险降低了，尤其是那些可能受到潜在的血管病理引起的痴呆症风险增加的人。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。 2025年4月4日。DOI：10.1161/CirculationAha.124.070632。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：共同的遗传和生活方式危险因素可能是冠状动脉疾病（CAD）和痴呆症的发展。我们检查了CAD的遗传风险增加是否与发展全因，阿尔茨海默氏症或血管性痴呆的长期风险有关，并研究了中期至后期潜在可修改的生活方式因素的差异是否会减轻这种风险。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在英国生物银行队列内进行基线评估后至少5年，对365 782名参与者的前瞻性队列研究至少5年。使用全基因组的多基因风险评分（PRS）评估了遗传风险，用于CAD和生活方式风险，使用美国心脏协会生命的8生活方式风险评分（LRS）的改良版本。两个分数的较高值被认为代表了增加的风险。主要结果是全因，阿尔茨海默氏症和从电子健康记录获得的血管痴呆诊断。次要结果是在32 028名参与者中测量的神经影像型，用于磁共振成像。进行敏感性分析以测试生物学和行为风险因素导致观察到的关联的程度。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在中位数13。9年的随访中，总共观察到了8870例全因痴呆症。 CAD的遗传（PRS）和生活方式（LRS）风险评分都与全因痴呆症的风险适度升高有关（每SD次数增加，1.10 [1.08，1.12]， <i>P</i> &lt;0.001，PRS，PRS和1.04 [1.04 [1.02，1.06]，P = 0.006， <i>p</i> = 0.006，for LRS）。这种风险似乎在很大程度上归因于潜在的血管性痴呆诊断（亚chazard比率，1.16 [1.11，1.21]，PRS的<i>p</i> &lt;0.001和1.15 [1.09，1.22]， <i>p</i> &lt;0.001，p &lt;0.001，对于LRS），因为Alzheimer的疾病是单独使用的9. prauss（Sub）。 1.13]; <i>p</i> &lt;0.001）。发现LRS与PRS具有额外的而不是交互作用，而在随访过程中，CAD的遗传和生活方式风险最高的个体可能会出现血管性痴呆的可能性高70％，而subhazard比率最低的人（1.71 [1.39，2.11]; P &lt;0.001; <i>p</i> &lt;0.001）。在基线时LRS低的患者中，这显然是减弱的，但是，无论遗传风险是什么（低LRS tertile，无论PRS三位一体如何降低40％至50％；所有人的<i>P</i> &lt;0.001）。召回神经影像学评估的个体的一部分，对CAD的遗传和生活方式风险最高的人的白质高压强度比最低风险颗粒的人表现出约25％的白质超强度，但在灰质或海马体积上显示的差异很小。敏感性分析确定了生物学和行为风险评分与白质高强度伯嫩和血管痴呆之间的关联，而某些阿尔茨海默氏症的痴呆症相关表现出了看似悖论的关系。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在遗传上易于发展CAD的个体也面临着在老年内发展痴呆症的风险。在寿命早期证明健康生活方式概况的人中，这种风险降低了，尤其是那些可能受到潜在的血管病理引起的痴呆症风险增加的人。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40181791/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40181791</a> | doi： <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070632>10.1161/CirculationAha.124.070632</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40181791</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Arisa Sittichokkananon</dc:creator><dc:creator>维多利亚·加菲猫</dc:creator><dc:creator>Scott T Chiesa</dc:creator><dc:date> 2025-04-04</dc:date><dc:source>循环</dc:source><dc:title>冠状动脉疾病的遗传和生活方式风险以及出现痴呆症亚型的长期风险</dc:title><dc:identifier>PMID：40181791</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.124.070632</dc:identifier></item><item><title> PASMC中的压电1：对于缺氧诱导的肺高血压发育至关重要</title><link/>https://pubmed.ncbi.nlm.nih.gov/40181773/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>结论：这项研究提供了证据，表明通过控制肺血管张力，动脉重塑和相关的肺毛细血管稀有性，在PASMC中表达的压电与pH的发病机理至关重要。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res。 2025年4月4日。doi：10.1161/circresaha.124.325475。在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：肺动脉高压（pH）是一种威胁生命，进行性而无法治愈的疾病。 PH的标志包括（1）持续收缩和（2）肺动脉平滑肌细胞（PASMC）的过度增殖。 PH发育过程中PASMC暴露的主要刺激是机械应力改变，源于血压升高，血流速度的变化以及肺动脉的逐渐僵硬。机械敏感的离子通道，包括压电1，感知这种机械刺激，并将其转化为各种细胞反应，包括收缩性或增殖。这是本研究的目的是阐明压电1在PASMC中的特定作用在pH发育和进展中。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在（1）PASMC和肺组织中评估了PH和（2）2个小鼠菌株的细胞类型特异性功能，其特征是平滑肌细胞特异性，有条件的Piezo1敲除。利用这些菌株，在分离，灌注和通风的小鼠肺，电线肌电图和增殖分析中评估了压电1在pH发育和进展中的平滑肌细胞特异性作用。最后，在这些小鼠中诱导慢性缺氧诱导的pH值时，评估了平滑肌细胞特异性压电1敲除的体内功能，并洞悉肺血管细胞感应。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：与健康对照相比，来自pH的患者的PASMC具有升高的压电表达和增殖表型的升高。通过定量的实时聚合酶链反应和斑块夹记录证实，平滑肌细胞特异性的压电1缺失阻止了小鼠PASMC增殖的缺氧增加。此外，压电敲除减少了孤立，灌注和通风小鼠肺，内皮抑制的肺动脉和体内血液动力学测量的低氧肺血管收缩。因此，通过改善右心肥大和改善的血液动力学功能，认为对压电1缺陷小鼠被认为免受慢性缺氧诱导的pH发育的保护。另外，在压电1-敲除小鼠中保留了盘状肺毛细血管，与较低的感觉内皮细胞有关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这项研究提供了证据，表明通过控制肺血管张力，动脉重塑和相关的肺毛细血管稀有性，在PASMC中表达的压电与pH的发病机理至关重要。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40181773/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40181773</a> | doi： <a href=https://doi.org/10.1161/CIRCRESAHA.124.325475>10.1161/circresaha.124.325475</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40181773</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Fenja Knoepp</dc:creator><dc:creator> Shariq Abid</dc:creator><dc:creator>阿马尔·霍斯海尼（Amal Houssaini）</dc:creator><dc:creator> Larissa Lipskaia</dc:creator><dc:creator> MiraYaseminGökyildirim</dc:creator><dc:creator> Emmanuelle出生</dc:creator><dc:creator>伊丽莎白·马科斯（Elisabeth Marcos）</dc:creator><dc:creator>马利卡·阿哈特（Malika Arhatte）</dc:creator><dc:creator> Edyta Glogowska</dc:creator><dc:creator>诺拉·维也纳</dc:creator><dc:creator>安德烈亚斯·古恩特（AndreasGünther）</dc:creator><dc:creator>西蒙妮·克劳特（Simone Kraut）</dc:creator><dc:creator> Ingrid Breitenborn-Mueller</dc:creator><dc:creator>卡林·昆兹（Karin Quanz）</dc:creator><dc:creator>达格玛芬纳 - 瑙</dc:creator><dc:creator>GenevièveDerumeaux</dc:creator><dc:creator>诺伯特·魏斯曼</dc:creator><dc:creator>EricHonoré</dc:creator><dc:creator> Serge Adnot</dc:creator><dc:date> 2025-04-04</dc:date><dc:source>循环研究</dc:source><dc:title>PASMC中的压电1：对于缺氧诱导的肺高血压发育至关重要</dc:title><dc:identifier>PMID：40181773</dc:identifier><dc:identifier> doi：10.1161/circresaha.124.325475</dc:identifier></item><item><title> PCR伦敦瓣</title><link/>https://pubmed.ncbi.nlm.nih.gov/40181574/?utm_source = chrome&amp;utm_medium = rsss＆utm_campaign=pubmed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU8003KRCPQ8YLQC-＆FC = 20230708114047＆ff = 20250406161126＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 APR 4：EHAF103。 doi：10.1093/eurheartj/ehaf103。在线印刷。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40181574/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40181574</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf103>10.1093/eurheartj/ehaf103</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：40181574</guid><pubDate> Fri, 04 Apr 2025 06:00:00 -0400</pubDate><dc:creator> PCR伦敦阀门课程和团队</dc:creator><dc:date>2025-04-04</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>PCR伦敦瓣</dc:title><dc:identifier>PMID：40181574</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf103</dc:identifier></item><item><title> Therapeutic potential of allosteric HECT E3 ligase inhibition</title><link/> https://pubmed.ncbi.nlm.nih.gov/40179885/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> Targeting ubiquitin E3 ligases is therapeutically attractive; however, the absence of an active-site pocket impedes computational approaches for identifying inhibitors. In a large, unbiased biochemical screen, we discover inhibitors that bind a cryptic cavity distant from the catalytic cysteine of the homologous to E6-associated protein C terminus domain (HECT) E3 ligase, SMAD ubiquitin regulatory factor 1 (SMURF1). Structural and biochemical analyses and engineered escape mutants revealed that... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2025 Apr 2:S0092-8674(25)00274-0. doi: 10.1016/j.cell.2025.03.001. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Targeting ubiquitin E3 ligases is therapeutically attractive; however, the absence of an active-site pocket impedes computational approaches for identifying inhibitors. In a large, unbiased biochemical screen, we discover inhibitors that bind a cryptic cavity distant from the catalytic cysteine of the homologous to E6-associated protein C terminus domain (HECT) E3 ligase, SMAD ubiquitin regulatory factor 1 (SMURF1). Structural and biochemical analyses and engineered escape mutants revealed that these inhibitors restrict an essential catalytic motion by extending an α helix over a conserved glycine hinge. SMURF1 levels are increased in pulmonary arterial hypertension (PAH), a disease caused by mutation of bone morphogenetic protein receptor-2 (BMPR2). We demonstrated that SMURF1 inhibition prevented BMPR2 ubiquitylation, normalized bone morphogenetic protein (BMP) signaling, restored pulmonary vascular cell homeostasis, and reversed pathology in established experimental PAH. Leveraging this deep mechanistic understanding, we undertook an in silico machine-learning-based screen to identify inhibitors of the prototypic HECT E6AP and confirmed glycine-hinge-dependent allosteric activity in vitro. Inhibiting HECTs and other glycine-hinge proteins opens a new druggable space.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40179885/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40179885</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2025.03.001>10.1016/j.cell.2025.03.001</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40179885</guid><pubDate> Thu, 03 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Alexander MK Rothman</dc:creator><dc:creator> Amir Florentin</dc:creator><dc:creator> Florence Zink</dc:creator><dc:creator> Catherine Quigley</dc:creator><dc:creator> Olivier Bonneau</dc:creator><dc:creator> Rene Hemmig</dc:creator><dc:creator> Amanda Hachey</dc:creator><dc:creator> Tomas Rejtar</dc:creator><dc:creator> Maulik Thaker</dc:creator><dc:creator> Rishi Jain</dc:creator><dc:creator> Shih-Min Huang</dc:creator><dc:creator> Daniel Sutton</dc:creator><dc:creator> Jan Roger</dc:creator><dc:creator> Ji-Hu Zhang</dc:creator><dc:creator> Sven Weiler</dc:creator><dc:creator> Simona Cotesta</dc:creator><dc:creator> Johannes Ottl</dc:creator><dc:creator> Salil Srivastava</dc:creator><dc:creator> Alina Kordonsky</dc:creator><dc:creator> Reut Avishid</dc:creator><dc:creator> Elon Yariv</dc:creator><dc:creator> Ritu Rathi</dc:creator><dc:creator> Oshrit Khvalevsky</dc:creator><dc:creator> Thomas Troxler</dc:creator><dc:creator> Sarah K Binmahfooz</dc:creator><dc:creator> Oded Kleifeld</dc:creator><dc:creator> Nicholas W Morrell</dc:creator><dc:creator> Marc Humbert</dc:creator><dc:creator> Matthew J Thomas</dc:creator><dc:creator> Gabor Jarai</dc:creator><dc:creator> Rohan EJ Beckwith</dc:creator><dc:creator> Jennifer S Cobb</dc:creator><dc:creator> Nichola Smith</dc:creator><dc:creator> Nils Ostermann</dc:creator><dc:creator> John Tallarico</dc:creator><dc:creator> Duncan Shaw</dc:creator><dc:creator> Sabine Guth-Gundel</dc:creator><dc:creator> Gali Prag</dc:creator><dc:creator> David J Rowlands</dc:creator><dc:date> 2025-04-03</dc:date><dc:source> Cell</dc:source><dc:title> Therapeutic potential of allosteric HECT E3 ligase inhibition</dc:title><dc:identifier> pmid:40179885</dc:identifier><dc:identifier> doi:10.1016/j.cell.2025.03.001</dc:identifier></item><item><title> Genetically encoded reporters of actin filament organization in living cells and tissues</title><link/> https://pubmed.ncbi.nlm.nih.gov/40179884/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> The cytoskeletal protein actin is crucial for cell shape and integrity throughout eukaryotes. Actin filaments perform essential biological functions, including muscle contraction, cell division, and tissue morphogenesis. These diverse activities are achieved through the ability of actin filaments to be arranged into precise architectures. Much progress has been made in defining the proteome of the actin cytoskeleton, but a detailed appreciation of the dynamic organizational state of the actin... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2025 Apr 1:S0092-8674(25)00276-4. doi: 10.1016/j.cell.2025.03.003. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> The cytoskeletal protein actin is crucial for cell shape and integrity throughout eukaryotes. Actin filaments perform essential biological functions, including muscle contraction, cell division, and tissue morphogenesis. These diverse activities are achieved through the ability of actin filaments to be arranged into precise architectures. Much progress has been made in defining the proteome of the actin cytoskeleton, but a detailed appreciation of the dynamic organizational state of the actin filaments themselves has been hindered by available tools. Fluorescence polarization microscopy is uniquely placed for measuring actin filament organization by exploiting the sensitivity of polarized light excitation to the orientation of fluorophores attached to actin filaments. By engineering fusions of five widely used actin localization reporters to fluorescent proteins with constrained mobility, we have succeeded in developing genetically encoded, green- and red-fluorescent-protein-based reporters for non-invasive, quantitative measurements of actin filament organization in living cells and tissues by fluorescence polarization microscopy.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40179884/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40179884</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2025.03.003>10.1016/j.cell.2025.03.003</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40179884</guid><pubDate> Thu, 03 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Carla Silva Martins</dc:creator><dc:creator> François Iv</dc:creator><dc:creator> Shashi Kumar Suman</dc:creator><dc:creator> Thomas C Panagiotou</dc:creator><dc:creator> Clara Sidor</dc:creator><dc:creator> María Ruso-López</dc:creator><dc:creator> Camille N Plancke</dc:creator><dc:creator> Shizue Omi</dc:creator><dc:creator> Rebecca Pagès</dc:creator><dc:creator> Maxime Gomes</dc:creator><dc:creator> Alexander Llewellyn</dc:creator><dc:creator> Sourish Reddy Bandi</dc:creator><dc:creator> Laurie Ramond</dc:creator><dc:creator> Federica Arbizzani</dc:creator><dc:creator> Caio Vaz Rimoli</dc:creator><dc:creator> Frank Schnorrer</dc:creator><dc:creator> François Robin</dc:creator><dc:creator> Andrew Wilde</dc:creator><dc:creator> Loïc LeGoff</dc:creator><dc:creator> Jean-Denis Pedelacq</dc:creator><dc:creator> Antoine Jégou</dc:creator><dc:creator> Stéphanie Cabantous</dc:creator><dc:creator> Sergio A Rincon</dc:creator><dc:creator> Cristel Chandre</dc:creator><dc:creator> Sophie Brasselet</dc:creator><dc:creator> Manos Mavrakis</dc:creator><dc:date> 2025-04-03</dc:date><dc:source> Cell</dc:source><dc:title> Genetically encoded reporters of actin filament organization in living cells and tissues</dc:title><dc:identifier> pmid:40179884</dc:identifier><dc:identifier> doi:10.1016/j.cell.2025.03.003</dc:identifier></item><item><title> A chemical radar allows bacteria to detect and kill predators</title><link/> https://pubmed.ncbi.nlm.nih.gov/40179883/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> Amoebal predation exerts a strong evolutionary selection pressure on bacteria, thus driving the development of effective predator-defense strategies. However, little is known about the molecular interplay between bacteria and predators, particularly how bacteria can sense and kill their microbial predators. We show how the ubiquitous bacterium Pseudomonas syringae detects and kills the social amoeba Polysphondylium pallidum. Combining comparative genomics, molecular biology, and chemical... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2025 Apr 1:S0092-8674(25)00269-7. doi: 10.1016/j.cell.2025.02.033. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Amoebal predation exerts a strong evolutionary selection pressure on bacteria, thus driving the development of effective predator-defense strategies. However, little is known about the molecular interplay between bacteria and predators, particularly how bacteria can sense and kill their microbial predators. We show how the ubiquitous bacterium Pseudomonas syringae detects and kills the social amoeba Polysphondylium pallidum. Combining comparative genomics, molecular biology, and chemical analyses, we identified a chemical radar system. The system relies on P. syringae secreting the lipopeptide syringafactin, which is deacylated by the amoeba. The resulting peptides are sensed via the bacterial sensor protein chemical radar regulator (CraR) that activates genes for converting the predator-derived signal into the amoebicide pyrofactin. This system is widespread in P. syringae and enables bacteria to infect A. thaliana in the presence of amoebae. Our study advances the understanding of microbial sensing and opens new avenues for the discovery of natural products.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40179883/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40179883</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2025.02.033>10.1016/j.cell.2025.02.033</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40179883</guid><pubDate> Thu, 03 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Shuaibing Zhang</dc:creator><dc:creator> Kevin Schlabach</dc:creator><dc:creator> Victor Hugo Pérez Carrillo</dc:creator><dc:creator> Anan Ibrahim</dc:creator><dc:creator> Shahran Nayem</dc:creator><dc:creator> Anna Komor</dc:creator><dc:creator> Ruchira Mukherji</dc:creator><dc:creator> Somak Chowdhury</dc:creator><dc:creator> Lisa Reimer</dc:creator><dc:creator> Felix Trottmann</dc:creator><dc:creator> A Corina Vlot</dc:creator><dc:creator> Christian Hertweck</dc:creator><dc:creator> Ute A Hellmich</dc:creator><dc:creator> Pierre Stallforth</dc:creator><dc:date> 2025-04-03</dc:date><dc:source> Cell</dc:source><dc:title> A chemical radar allows bacteria to detect and kill predators</dc:title><dc:identifier> pmid:40179883</dc:identifier><dc:identifier> doi:10.1016/j.cell.2025.02.033</dc:identifier></item><item><title> Cell membranes sustain phospholipid imbalance via cholesterol asymmetry</title><link/> https://pubmed.ncbi.nlm.nih.gov/40179882/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> Membranes are molecular interfaces that compartmentalize cells to control the flow of nutrients and information. These functions are facilitated by diverse collections of lipids, nearly all of which are distributed asymmetrically between the two bilayer leaflets. Most models of biomembrane structure and function include the implicit assumption that these leaflets have similar abundances of phospholipids. Here, we show that this assumption is generally invalid and investigate the consequences of... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2025 Mar 26:S0092-8674(25)00270-3. doi: 10.1016/j.cell.2025.02.034. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Membranes are molecular interfaces that compartmentalize cells to control the flow of nutrients and information. These functions are facilitated by diverse collections of lipids, nearly all of which are distributed asymmetrically between the two bilayer leaflets. Most models of biomembrane structure and function include the implicit assumption that these leaflets have similar abundances of phospholipids. Here, we show that this assumption is generally invalid and investigate the consequences of lipid abundance imbalances in mammalian plasma membranes (PMs). Using lipidomics, we report that cytoplasmic leaflets of human erythrocyte membranes have >;50% overabundance of phospholipids compared with exoplasmic leaflets. This imbalance is enabled by an asymmetric interleaflet distribution of cholesterol, which regulates cellular cholesterol homeostasis. These features produce unique functional characteristics, including low PM permeability and resting tension in the cytoplasmic leaflet that regulates protein localization.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40179882/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40179882</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2025.02.034>10.1016/j.cell.2025.02.034</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40179882</guid><pubDate> Thu, 03 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Milka Doktorova</dc:creator><dc:creator> Jessica L Symons</dc:creator><dc:creator> Xiaoxuan Zhang</dc:creator><dc:creator> Hong-Yin Wang</dc:creator><dc:creator> Jan Schlegel</dc:creator><dc:creator> Joseph H Lorent</dc:creator><dc:creator> Frederick A Heberle</dc:creator><dc:creator> Erdinc Sezgin</dc:creator><dc:creator> Edward Lyman</dc:creator><dc:creator> Kandice R Levental</dc:creator><dc:creator> Ilya Levental</dc:creator><dc:date> 2025-04-03</dc:date><dc:source> Cell</dc:source><dc:title> Cell membranes sustain phospholipid imbalance via cholesterol asymmetry</dc:title><dc:identifier> pmid:40179882</dc:identifier><dc:identifier> doi:10.1016/j.cell.2025.02.034</dc:identifier></item><item><title> Engineering sonogenetic EchoBack-CAR T cells</title><link/> https://pubmed.ncbi.nlm.nih.gov/40179881/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> Chimeric antigen receptor (CAR) T cell therapy for solid tumors encounters challenges such as on-target off-tumor toxicity, exhaustion, and limited T cell persistence. Here, we engineer sonogenetic EchoBack-CAR T cells using an ultrasensitive heat-shock promoter screened from a library and integrated with a positive feedback loop from CAR signaling, enabling long-lasting CAR expression upon focused-ultrasound (FUS) stimulation. EchoBack-hGD2CAR T cells, targeting disialoganglioside GD2,... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2025 Mar 23:S0092-8674(25)00271-5. doi: 10.1016/j.cell.2025.02.035. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Chimeric antigen receptor (CAR) T cell therapy for solid tumors encounters challenges such as on-target off-tumor toxicity, exhaustion, and limited T cell persistence. Here, we engineer sonogenetic EchoBack-CAR T cells using an ultrasensitive heat-shock promoter screened from a library and integrated with a positive feedback loop from CAR signaling, enabling long-lasting CAR expression upon focused-ultrasound (FUS) stimulation. EchoBack-hGD2CAR T cells, targeting disialoganglioside GD2, exhibited potent cytotoxicity and persistence in 3D glioblastoma (GBM) models. In mice, EchoBack-hGD2CAR T cells suppressed GBM without off-tumor toxicity and outperformed their constitutive counterparts. Single-cell RNA sequencing revealed enhanced cytotoxicity and reduced exhaustion in EchoBack-CAR T cells compared with the standard CAR T cells. This EchoBack design was further adapted to target prostate-specific membrane antigen (EchoBack-PSMACAR) for prostate cancer treatment, demonstrating long-lasting tumor suppression with minimal off-tumor toxicity. Thus, the sonogenetic EchoBack-CAR T cells can serve as a versatile, efficient, and safe strategy for solid tumor treatment.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40179881/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40179881</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2025.02.035>10.1016/j.cell.2025.02.035</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40179881</guid><pubDate> Thu, 03 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Longwei Liu</dc:creator><dc:creator> Peixiang He</dc:creator><dc:creator> Yuxuan Wang</dc:creator><dc:creator> Fengyi Ma</dc:creator><dc:creator> Dulei Li</dc:creator><dc:creator> Zhiliang Bai</dc:creator><dc:creator> Yunjia Qu</dc:creator><dc:creator> Linshan Zhu</dc:creator><dc:creator> Chi Woo Yoon</dc:creator><dc:creator> Xi Yu</dc:creator><dc:creator> Yixuan Huang</dc:creator><dc:creator> Zhengyu Liang</dc:creator><dc:creator> Yiming Zhang</dc:creator><dc:creator> Kunshu Liu</dc:creator><dc:creator> Tianze Guo</dc:creator><dc:creator> Yushun Zeng</dc:creator><dc:creator> Qifa Zhou</dc:creator><dc:creator> H Kay Chung</dc:creator><dc:creator> Rong Fan</dc:creator><dc:creator> Yingxiao Wang</dc:creator><dc:date> 2025-04-03</dc:date><dc:source> Cell</dc:source><dc:title> Engineering sonogenetic EchoBack-CAR T cells</dc:title><dc:identifier> pmid:40179881</dc:identifier><dc:identifier> doi:10.1016/j.cell.2025.02.035</dc:identifier></item><item><title> Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry</title><link/> https://pubmed.ncbi.nlm.nih.gov/40177743/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> CONCLUSIONS: One-year outcomes among real-world trial-eligible patients are excellent, but adverse events are higher compared with published clinical trial data, likely because of greater comorbidity burden and lower baseline Kansas City Cardiomyopathy Questionnaire score. These data can help inform expected outcomes and health status after low-risk TAVR. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2025 Apr 3. doi: 10.1161/CIRCULATIONAHA.124.071838. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of measuring the quality of clinical technology adoption. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We identified heart team-designated low-risk patients undergoing TAVR for trileaflet severe, symptomatic aortic stenosis in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Registry, as well as a subset of patients who met low-risk trial inclusion and exclusion criteria, from January 2020 to March 2024. Outcomes (mortality, stroke, new pacemaker, and &quot;alive and well,&quot; defined as alive at 1 year with Kansas City Cardiomyopathy Questionnaire score ≥60 and ≤10-point decrease from baseline) at 30 days and 1 year were assessed. Multivariable models were developed to assess predictors of death within 1 year after TAVR. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Among 383 030 patients who underwent TAVR during the study period, 108 407 (28%) were designated low risk by the heart team, and 68 194 (18%) met other study inclusion and exclusion criteria. Of these, 62% (n=42 093) would have been eligible for the low-risk trials. In the overall heart team-designated low-risk population, 30-day outcomes included 0.8% mortality, 1.5% stroke, and 8.4% new permanent pacemaker requirement; 1-year outcomes included 4.6% mortality, 2.6% stroke, and 90% alive and well. In the trial-eligible population, 0.6% mortality, 1.4% stroke, and 8.0% new permanent pacemaker requirement had occurred by 30 days; values at 1 year included 3.1% mortality, 2.4% stroke, and 92% alive and well. Notable multivariable predictors of 1-year mortality were atrial fibrillation, nontransfemoral access, and lower baseline Kansas City Cardiomyopathy Questionnaire score. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: One-year outcomes among real-world trial-eligible patients are excellent, but adverse events are higher compared with published clinical trial data, likely because of greater comorbidity burden and lower baseline Kansas City Cardiomyopathy Questionnaire score. These data can help inform expected outcomes and health status after low-risk TAVR.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40177743/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40177743</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071838>10.1161/CIRCULATIONAHA.124.071838</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40177743</guid><pubDate> Thu, 03 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Andrew M Vekstein</dc:creator><dc:creator> Zachary K Wegermann</dc:creator><dc:creator> Pratik Manandhar</dc:creator><dc:creator> Michael J Mack</dc:creator><dc:creator> David J Cohen</dc:creator><dc:creator> G Chad Hughes</dc:creator><dc:creator> J Kevin Harrison</dc:creator><dc:creator> Tsuyoshi Kaneko</dc:creator><dc:creator> Samir R Kapadia</dc:creator><dc:creator> Konstantinos Stathogiannis</dc:creator><dc:creator> William F Fearon</dc:creator><dc:creator> Suzanne Arnold</dc:creator><dc:creator> Andrzej S Kosinski</dc:creator><dc:creator> Martin B Leon</dc:creator><dc:creator> Wayne B Batchelor</dc:creator><dc:creator> Vinod H Thourani</dc:creator><dc:creator> Sreekanth Vemulapalli</dc:creator><dc:date> 2025-04-03</dc:date><dc:source> Circulation</dc:source><dc:title> Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry</dc:title><dc:identifier> pmid:40177743</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.124.071838</dc:identifier></item><item><title> Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target</title><link/> https://pubmed.ncbi.nlm.nih.gov/40175709/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> Clonal haematopoiesis is the clonal expansion of blood stem cells with acquired mutations. Clonal haematopoiesis of indeterminate potential (CHIP), traditionally defined as clonal haematopoiesis driven by a pre-leukaemic mutation in at least 2% of sequenced alleles, affects 10-20% of individuals aged >;70 years. Although CHIP is considered a precursor condition for haematological malignancies, population-based data suggest that the majority of CHIP-associated mortality is attributable to... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol. 2025 Apr 2. doi: 10.1038/s41569-025-01148-9. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Clonal haematopoiesis is the clonal expansion of blood stem cells with acquired mutations. Clonal haematopoiesis of indeterminate potential (CHIP), traditionally defined as clonal haematopoiesis driven by a pre-leukaemic mutation in at least 2% of sequenced alleles, affects 10-20% of individuals aged >;70 years. Although CHIP is considered a precursor condition for haematological malignancies, population-based data suggest that the majority of CHIP-associated mortality is attributable to non-malignant conditions, such as cardiovascular disease. Observational human studies have shown that CHIP is a strong and independent predictor of the onset and progression of atherosclerotic cardiovascular disease, heart failure and arrhythmia. In addition, findings from animal experiments suggest that CHIP is causally involved in these diseases and might be a risk factor that can be targeted with therapeutics. As our understanding of the cardiovascular implications of CHIP and other types of clonal haematopoiesis rapidly expands, it has become increasingly clear that clonal haematopoiesis subtypes have substantial heterogeneity with respect to magnitude of effect and underlying mechanisms for different cardiovascular diseases. In this Review, we discuss clonal haematopoiesis as a prognostic factor for numerous cardiovascular diseases, highlight its potential as a therapeutic target and propose a potential role for CHIP in cardiovascular precision medicine.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40175709/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40175709</a> | DOI: <a href=https://doi.org/10.1038/s41569-025-01148-9>10.1038/s41569-025-01148-9</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40175709</guid><pubDate> Wed, 02 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Art Schuermans</dc:creator><dc:creator> Michael C Honigberg</dc:creator><dc:date> 2025-04-02</dc:date><dc:source> Nature reviews. Cardiology</dc:source><dc:title> Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target</dc:title><dc:identifier> pmid:40175709</dc:identifier><dc:identifier> doi:10.1038/s41569-025-01148-9</dc:identifier></item><item><title> Tunnelling nanotube-like structures facilitate cell-cell communication during heart development</title><link/> https://pubmed.ncbi.nlm.nih.gov/40175708/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250406161126&amp;v=2.18.0.post9+e462414<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol. 2025 Apr 2. doi: 10.1038/s41569-025-01151-0. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40175708/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250406161126&v=2.18.0.post9+e462414">40175708</a> | DOI: <a href=https://doi.org/10.1038/s41569-025-01151-0>10.1038/s41569-025-01151-0</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:40175708</guid><pubDate> Wed, 02 Apr 2025 06:00:00 -0400</pubDate><dc:creator> Karina Huynh</dc:creator><dc:date> 2025-04-02</dc:date><dc:source> Nature reviews. Cardiology</dc:source><dc:title> Tunnelling nanotube-like structures facilitate cell-cell communication during heart development</dc:title><dc:identifier> pmid:40175708</dc:identifier><dc:identifier> doi:10.1038/s41569-025-01151-0</dc:identifier></item></channel></rss>